Showing results (41-50 of 410) with videos related to
Sort By:
Pageof 41
Clinical Nuclear Medicine|February 16, 2026
Early Detection of Neuroblastoma Recurrence on 18F mFBG PETNeeta Pandit-Taskar, Anita Price, Gerald Behr, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2013
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancerMary L Gemignani, Sujata Patil, Venkatraman E Seshan, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapyNeeta Pandit-Taskar, Joseph A O'Donoghue, Michael J Morris, et al.Pediatric Blood & Cancer|November 3, 2016
Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paragangliomaSameer Sait, Rachel Kobos, Michael P LaQuaglia, et al.Current Oncology Reports|April 7, 2004
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancerMichael J Morris, Neeta Pandit-Taskar, Chaitanya Divgi, et al.Current Urology Reports|May 5, 2005
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancerMichael J Morris, Neeta Pandit-Taskar, Chaitanya Divgi, et al.Translational Oncology|May 6, 2022
Assessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and managementSonia Mahajan, Ravinder K Grewal, Kent P Friedman, et al.Nanotheranostics|February 28, 2022
Molecular Immune Targeted Imaging of Tumor MicroenvironmentTaha Rakhshandehroo, Bryan Ronain Smith, Hannah J Glockner, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2020
IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab-pharmacokinetic modeling to optimize therapeutic indexRahul S Yerrabelli, Ping He, Edward K Fung, et al.Clinical Nuclear Medicine|August 1, 2017
Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG ImagingNeeta Pandit-Taskar, Pat Zanzonico, Patrick Hilden, et al.Pageof 41